By Howard Dean All Democrats and many Republicans are committed to making prescription drugs more affordable. There is one strategy that is likely to make things worse: overriding patents on drugs developed with the help of federally funded research. This “march-in” option is not a good idea. It hinges on the Bayh-Dole Act, a 40-year-old […]
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MADISON TIMES
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MADISON TIMES
Price Controls Rob Patients of Future Therapies
By Peter J. Pitts President Donald Trump just announced a sweeping executive order that’d forbid Medicare from paying more for advanced medicines than any other developed country. This price control scheme, if implemented, would sound a death knell for medical innovation – and potentially for many patients. Drug development is expensive, time-consuming and full of […]
Trump Administration Ends Pharmacy Coupons When Patients Need Them Most
By Peter J. Pitts For chronically ill Americans, the economic damage from COVID-19 could be nearly as life-threatening as the virus itself. More than 40 million workers have filed for unemployment since the beginning of the outbreak. For many, the financial challenges of joblessness have made it harder than ever to afford their insurance companies’ […]
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MADISON TIMES
Price Controls Punish U.S. Innovators and Economy
By Sally C. Pipes America’s biopharmaceutical industry dwarfs most other economic sectors. It’s one of our nation’s single biggest job creators, supporting close to a million positions across the country. And its products save countless lives each year. Yet for some reason, politicians in both parties seem determined to snuff it out by imposing crippling […]
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MADISON TIMES
Sharp Cuts to Research Funding Would Deprive Patients of Hope
By Mary Stabile Congress is poised to pass two separate bills designed to bring down drug prices. House Democrats and Senate Republicans are advancing bills that would set prices on prescription medicines, both directly and indirectly. The House plan would allow the government to arbitrarily dictate the prices of 250 medicines, reducing drug companies’ revenues […]
AARP Talks the Rising Cost of Prescription Medication
By Ana Martinez-Ortiz Nancy Koch knows physical pain. She has a chronic auto immune disease, that won’t get better and is most likely only going to get worse. To help keep her body functioning, Koch takes medication, the catch is that it costs $4,000 a month. Koch is not alone, when it comes to the […]